CoChat

The Interplay of Cofactor Interactions and Post-translational Modifications in the Regulation of the AAA+ ATPase p97

Open access
Hänzelmann, Petra, Schindelin, Hermann · 2017 · Frontiers in Molecular Biosciences
Cited by 160

The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.

Abstract

The hexameric type II AAA ATPase (ATPase associated with various activities) p97 (also referred to as VCP, Cdc48, and Ter94) is critically involved in a variety of cellular activities including pathways such as DNA replication and repair which both involve chromatin remodeling, and is a key player in various protein quality control pathways mediated by the ubiquitin proteasome system as well as autophagy. Correspondingly, p97 has been linked to various pathophysiological states including cancer, neurodegeneration, and premature aging. p97 encompasses an N-terminal domain, two highly conserved ATPase domains and an unstructured C-terminal tail. This enzyme hydrolyzes ATP and utilizes the resulting energy to extract or disassemble protein targets modified with ubiquitin from stable protein assemblies, chromatin and membranes. p97 participates in highly diverse cellular processes and hence its activity is tightly controlled. This is achieved by multiple regulatory cofactors, which either associate with the N-terminal domain or interact with the extreme C-terminus via distinct binding elements and target p97 to specific cellular pathways, sometimes requiring the simultaneous association with more than one cofactor. Most cofactors are recruited to p97 through conserved binding motifs/domains and assist in substrate recognition or processing by providing additional molecular properties. A tight control of p97 cofactor specificity and diversity as well as the assembly of higher-order p97-cofactor complexes is accomplished by various regulatory mechanisms, which include bipartite binding, binding site competition, changes in oligomeric assemblies, and nucleotide-induced conformational changes. Furthermore, post-translational modifications (PTMs) like acetylation, palmitoylation, phosphorylation, SUMOylation, and ubiquitylation of p97 have been reported which further modulate its diverse molecular activities. In this review, we will describe the molecular basis of p97-cofactor specificity/diversity and will discuss how PTMs can modulate p97-cofactor interactions and affect the physiological and patho-physiological functions of p97.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmolb.2017.00021

Cites

141 of 141 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • PhosphoSitePlus, 2014: mutations, PTMs and recalibrations

    Hornbeck, P. V., Zhang, B., Murray, B., Kornhauser, J. M., Latham, V., & Skrzypek, E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1267 · Cited by 3,411 · cited 16×

    “Numerous high-throughput proteomic studies revealed that p97 is extensively targeted by PTMs like phosphorylation (66 identified sites), ubiquitylation (38 identified sites) and acetylation (24 identified sites) (PhosphoSitePlus, http://www. phosphosite.org, Hornbeck et al., 2015), however, the relevant enzymes and fu…”
    BackgroundMethodInfluential
  • Signal transduction by reactive oxygen species

    Finkel, T. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102095 · Cited by 2,322 · cited 2×

    “The ε-amino group of lysine may be modified with up to three methyl groups by lysine-specific methyltransferases (KMTs) and the side chain of arginine may be mono- or di-methylated by arginine methyltransferases (PRMTs; reviewed in Biggar and Li, 2015).”
    Background
  • Systematic and Quantitative Assessment of the Ubiquitin-Modified Proteome

    Kim, W., Bennett, E. J., Huttlin, E. L., Guo, A., Li, J., Possemato, A., Sowa, M. E., Rad, R., Rush, J., Comb, M. J., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.025 · Cited by 1,613 · cited 3×

    “…the DUBOTU1 (yeast homolog of mammalian YOD1) in complex with the N domain also features a loop (YPP motif) inserting into the hydrophobic pocket (Kim et al., 2011a), whereas the UBXL domain of NPL4 does not feature an extended loop and binds differently (Isaacson et al., 2007; Hao et al., 2015)…”
    Background
  • Modification of Proteins by Ubiquitin and Ubiquitin-Like Proteins

    Kerscher, O., Felberbaum, R., & Hochstrasser, M. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010605.093503 · Cited by 1,517 · cited 1×

    “Covalent ubiquitin-protein conjugates are introduced in a series of three consecutive enzymatic steps (reviewed in Kerscher et al., 2006; Cappadocia and Lima, 2017).”
    Background
  • The increasing complexity of the ubiquitin code

    Yau, R., & Rape, M. (2016) · Nature Cell Biology · doi:10.1038/ncb3358 · Cited by 1,054 · cited 2×

    “Modifications with ubiquitin are highly variable in length and linkage type (reviewed in Akutsu et al., 2016; Yau and Rape, 2016).”
    Background
  • The Age of Crosstalk: Phosphorylation, Ubiquitination, and Beyond

    Hunter, T. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.019 · Cited by 942 · cited 3×

    “, 2014), can be either positive or negative (Hunter, 2007).”
    Background
  • A Proteome-wide, Quantitative Survey of In Vivo Ubiquitylation Sites Reveals Widespread Regulatory Roles

    Wagner, S. A., Beli, P., Weinert, B. T., Nielsen, M. L., Cox, J., Mann, M., & Choudhary, C. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.013284 · Cited by 889 · cited 1×

    “Several high-throughput proteomic analysis, which focused on ubiquitylation sites, identified a large number of p97 lysine residues that are ubiquitylated (Danielsen et al., 2011; Kim et al., 2011b; Wagner et al., 2011, 2012; Mertins et al., 2013; Elia et al., 2015; Wu et al., 2015).”
    Background
  • Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system

    Meyer, H., Bug, M., & Bremer, S. (2012) · Nature Cell Biology · doi:10.1038/ncb2407 · Cited by 807 · cited 2×

    “…et al., 2008; Ewens et al., 2010; Niwa et al., 2012). p97 participates in many different cellular pathways involved in the regulation of protein homeostasis, membrane fusion and vesicular trafficking as well as chromatin-associated functions (reviewed in Meyer et al., 2012; Meyer and Weihl, 2014).”
    Background
  • The world of protein acetylation

    Drazic, A., Myklebust, L. M., Ree, R., & Arnesen, T. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.06.007 · Cited by 804 · cited 2×

    “Malfunctions of the acetylation machinery have been implicated in cardiovascular and neurodegenerative diseases as well as cancer (Drazic et al., 2016).”
    Background
  • Phosphorylation-Dependent Ubiquitination of Cyclin E by the SCF Fbw7 Ubiquitin Ligase

    Koepp, D. M., Schaefer, L. K., Ye, X., Keyomarsi, K., Chu, C., Harper, J. W., & Elledge, S. J. (2001) · Science · doi:10.1126/science.1065203 · Cited by 762 · cited 2×

    “Phosphorylation-dependent ubiquitylation (Koepp et al., 2001) and SUMOylation (Hietakangas et al., 2006) represent examples of positive crosstalk where the initial PTM serves as active trigger for the subsequent addition or removal of a second PTM, or as a recognition site for other proteins.”
    Background

Show all 141 references

Cited by

Metadata

Authors
Hänzelmann, P., & Schindelin, H.
Venue
Frontiers in Molecular Biosciences
Published
2017-04-13
Volume
4
Pages
21-21
ISSN
2296-889X (ISSN-L)
OpenAlex
W2606154134
Cited by
160
References
141
FWCI
4.85
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.